Does Premedıcatıon wıth Mıdazolam Reduce Preoperatıve Anxıety Through Menstrular Cycle Phases?

Abstract

Aim: In this study, it was aimed to investigate and compare the effects of menstrual cycle phases on preoperative anxiety and postoperative pain scores in patients given midazolam for premedication before anesthesia. Methods: Septorhinoplasty, goiter surgery and laparoscopic cholecystectomy 126 female patients, aged 21-45, with American Society of Anesthesiologists (ASA) score I-II and with regular menstrual cycles, were included. Of the cases; The phase of the menstrual cycle was recorded according to the last menstrual period (SAT) and accordingly the patients were divided into 3 groups as Follicular phase, the Ovulatory phase, and the Luteal phase. Anxiety assessment was performed using the State-Trait Anxiety Inventory (STAI FORM TX-1) test. Anxiety scores were evaluated by performing a preoperative test 3 minutes before and 1 hour after intravenous (IV) administration of 0.02 mg/kg midazolam. Visual analog scale (VAS) was used for postoperative pain assessment. Results: Midazolam was found to decrease STAI FORM TX-1 scores the most during the ovulatory phase of the menstrual cycle, but there was no significant difference between the groups in terms of VAS scores. Conclusion: It has been observed that premedication with midazolam reduces preoperative anxiety in all phases of the menstrual cycle in women of reproductive age, but is most effective in the ovulatory phase. The effect of premedication with midazolam on postoperative pain does not change according to the phases of the menstrual cycle.